CLINICAL_TRIALS
trial_result
· 2022-10-24
Clinical Trial Update: Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients [Phase 2]
Summary
Phase 2 clinical trial update on using crofelemer to prevent diarrhea in HER2-positive breast cancer patients has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sandra Swain | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-10-24